REsiduAL rISk Under Intensive Lipid-lowering Therapy In Coronary Heart Disease

NCT06936111 · clinicaltrials.gov ↗
RECRUITING
Status
900
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Shanghai Zhongshan Hospital